KLP Kapitalforvaltning AS Has $90,000 Stock Position in Phibro Animal Health Corporation (NASDAQ:PAHC)

Key Points

• KLP Kapitalforvaltning AS drastically reduced its stake in Phibro Animal Health Corporation by 90.6% in the first quarter, now holding only 4,200 shares valued at $90,000.
• Phibro Animal Health reported a Q1 earnings per share of $0.63, surpassing analysts' estimates of $0.52, but revenue was slightly below expectations at $347.80 million.
• The company declared a quarterly dividend of $0.12 per share, representing an annual yield of 1.8%, with the next payout scheduled for September 24.

KLP Kapitalforvaltning AS decreased its holdings in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 90.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,200 shares of the company's stock after selling 40,500 shares during the period. KLP Kapitalforvaltning AS's holdings in Phibro Animal Health were worth $90,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in PAHC. Axecap Investments LLC bought a new position in shares of Phibro Animal Health during the 1st quarter valued at about $3,696,000. Millennium Management LLC boosted its position in shares of Phibro Animal Health by 233.0% during the 4th quarter. Millennium Management LLC now owns 207,749 shares of the company's stock valued at $4,363,000 after purchasing an additional 145,359 shares in the last quarter. Jacobs Levy Equity Management Inc. boosted its position in shares of Phibro Animal Health by 56.7% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company's stock valued at $6,325,000 after purchasing an additional 108,918 shares in the last quarter. Nuveen Asset Management LLC boosted its position in shares of Phibro Animal Health by 21.4% during the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock valued at $12,348,000 after purchasing an additional 103,618 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its position in shares of Phibro Animal Health by 357.1% during the 4th quarter. Alliancebernstein L.P. now owns 130,000 shares of the company's stock valued at $2,730,000 after purchasing an additional 101,560 shares in the last quarter. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Stock Down 1.5%

Phibro Animal Health stock traded down $0.39 during trading hours on Friday, hitting $26.11. The company had a trading volume of 356,504 shares, compared to its average volume of 303,453. Phibro Animal Health Corporation has a fifty-two week low of $16.16 and a fifty-two week high of $31.80. The company has a debt-to-equity ratio of 2.67, a current ratio of 2.91 and a quick ratio of 1.23. The firm has a market capitalization of $1.06 billion, a P/E ratio of 33.47, a price-to-earnings-growth ratio of 0.44 and a beta of 0.80. The firm's fifty day moving average is $26.64 and its 200-day moving average is $23.25.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. The company had revenue of $347.80 million during the quarter, compared to the consensus estimate of $352.41 million. On average, research analysts forecast that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Shareholders of record on Wednesday, September 3rd will be given a $0.12 dividend. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 dividend on an annualized basis and a yield of 1.8%. Phibro Animal Health's dividend payout ratio is presently 61.54%.

Analyst Upgrades and Downgrades

PAHC has been the subject of several research reports. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective for the company in a research report on Monday, June 16th. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and raised their target price for the stock from $25.00 to $35.00 in a report on Monday, July 7th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. Finally, Morgan Stanley set a $26.00 target price on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a report on Wednesday, June 25th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $24.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.